This improvement may be due to clinicians adjusting the treatment protocol based on the patients specific characteristics during subsequent ovarian stimulations, such as modifying the dose of ovulation-promoting medication and the timing of the trigger
None of the GLP-1 RAs should be used during pregnancy and individuals of childbearing potential are advised to use effective contraception
Early post-marketing surveillance and case reports raised initial concerns, prompting extensive investigation through randomised controlled trials, observational studies, and meta-analyses
In this report we demonstrate the efficacy of multiplexing the CellTox Green Cytotoxicity Assay with the GSH/GSSG-Glo Assay to determine both the cytotoxic and oxidative effects of compounds on cultured cells in a single assay plate
Esposito, K., Chiodini, P., Colao, A., Lenzi, A